ArticleFrontiers in oncology2023

Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.

Valeria J Sarapura Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.